Lyn Wiesinger, Commercial Director, North America at Swedish Orphan Biovitrum, presented at last year's World Orphan Drug Congress USA on the topic âSwedish Orphan Biovitrum: Profile of a rare disease therapeutic company.'
Do you want to learn more about:
- Product access in rare diseases
- Commercial challenges and solutions
- Professional and patient education in rare diseases
If so, you need to check out the video below: